489 related articles for article (PubMed ID: 34351742)
1. Aromatic Cadinane Sesquiterpenoids from the Fruiting Bodies of
Li X; Gao J; Li M; Cui H; Jiang W; Tu ZC; Yuan T
J Nat Prod; 2021 Aug; 84(8):2385-2389. PubMed ID: 34351742
[TBL] [Abstract][Full Text] [Related]
2. Identifying compounds that prevent the binding of the SARS-CoV-2 S-protein to ACE2.
Benítez-Cardoza CG; Vique-Sánchez JL
Comput Biol Med; 2021 Sep; 136():104719. PubMed ID: 34358993
[TBL] [Abstract][Full Text] [Related]
3. Withanone from
Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
[TBL] [Abstract][Full Text] [Related]
4. Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents.
Mei J; Zhou Y; Yang X; Zhang F; Liu X; Yu B
J Ethnopharmacol; 2021 Oct; 278():114303. PubMed ID: 34102269
[TBL] [Abstract][Full Text] [Related]
5. Tinocordiside from
Balkrishna A; Pokhrel S; Varshney A
Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
[TBL] [Abstract][Full Text] [Related]
6. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries.
David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A
Molecules; 2021 May; 26(11):. PubMed ID: 34072087
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
8. Screening of potential spike glycoprotein / ACE2 dual antagonists against COVID-19 in silico molecular docking.
Yu R; Li P
J Virol Methods; 2022 Mar; 301():114424. PubMed ID: 34896453
[TBL] [Abstract][Full Text] [Related]
9. Computational design of ultrashort peptide inhibitors of the receptor-binding domain of the SARS-CoV-2 S protein.
Pei P; Qin H; Chen J; Wang F; He C; He S; Hong B; Liu K; Qiao R; Fan H; Tong Y; Chen L; Luo SZ
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34180984
[TBL] [Abstract][Full Text] [Related]
10. An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.
Han S; Zhao G; Wei Z; Chen Y; Zhao J; He Y; He YJ; Gao J; Chen S; Du C; Wang T; Sun W; Huang Y; Wang C; Wang J
Peptides; 2021 Nov; 145():170638. PubMed ID: 34419496
[TBL] [Abstract][Full Text] [Related]
11. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
[TBL] [Abstract][Full Text] [Related]
12. Phytoconstituents from Moringa oleifera fruits target ACE2 and open spike glycoprotein to combat SARS-CoV-2: An integrative phytochemical and computational approach.
Siddiqui S; Ahmad R; Alaidarous M; Zia Q; Ahmad Mir S; Alshehri B; Srivastava A; Trivedi A
J Food Biochem; 2022 May; 46(5):e14062. PubMed ID: 35043973
[TBL] [Abstract][Full Text] [Related]
13. Tetracycline as an inhibitor to the SARS-CoV-2.
Zhao TY; Patankar NA
J Cell Biochem; 2021 Jul; 122(7):752-759. PubMed ID: 33619758
[TBL] [Abstract][Full Text] [Related]
14. The molecular dynamics of possible inhibitors for SARS-CoV-2.
Irani AH; Steyn-Ross DA; Steyn-Ross ML; Voss L; Sleigh J
J Biomol Struct Dyn; 2022; 40(20):10023-10032. PubMed ID: 34229582
[TBL] [Abstract][Full Text] [Related]
15. Cadinane- and drimane-type sesquiterpenoids produced by Paecilomyces sp. TE-540, an endophyte from Nicotiana tabacum L., are acetylcholinesterase inhibitors.
Xu K; Zhou Q; Li XQ; Luo T; Yuan XL; Zhang ZF; Zhang P
Bioorg Chem; 2020 Nov; 104():104252. PubMed ID: 32911187
[TBL] [Abstract][Full Text] [Related]
16.
Tiwari V
Biol Open; 2020 Oct; 9(10):. PubMed ID: 32878881
[TBL] [Abstract][Full Text] [Related]
17. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19.
Ma LL; Liu HM; Liu XM; Yuan XY; Xu C; Wang F; Lin JZ; Xu RC; Zhang DK
Eur J Med Chem; 2021 Dec; 226():113857. PubMed ID: 34628234
[TBL] [Abstract][Full Text] [Related]
18. Luteolin inhibits spike protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) binding to angiotensin-converting enzyme 2.
Zhu J; Yan H; Shi M; Zhang M; Lu J; Wang J; Chen L; Wang Y; Li L; Miao L; Zhang H
Phytother Res; 2023 Aug; 37(8):3508-3521. PubMed ID: 37166054
[TBL] [Abstract][Full Text] [Related]
19. Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.
Pokhrel S; Bouback TA; Samad A; Nur SM; Alam R; Abdullah-Al-Mamun M; Nain Z; Imon RR; Talukder MEK; Tareq MMI; Hossen MS; Karpiński TM; Ahammad F; Qadri I; Rahman MS
Int J Biol Macromol; 2021 Nov; 191():1114-1125. PubMed ID: 34592225
[TBL] [Abstract][Full Text] [Related]
20. Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors.
Singh R; Bhardwaj VK; Sharma J; Kumar D; Purohit R
Comput Biol Med; 2021 Sep; 136():104631. PubMed ID: 34273770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]